SEC Form 4 · accession 0000899243-19-001954
Solid Biosciences Inc. · SLDB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joel Solomon Zev Schneider
Officer — See Remarks
Period of report
Jan 23, 2019
Accepted (ET)
Jan 25, 2019 · 5:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001707502
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $22.93 | Jan 23, 2019 | A | 60,000 | A | — | Jan 23, 2029 | Common Stock | 60,000 | 60,000 | D |
Explanation of responses
- F1This option was granted on January 23, 2019 and vests in four equal annual installments on the anniversary of the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events and the termination of the Reporting Person's employment under specified circumstances.
Remarks
Chief Technology Officer and Head of Exploratory R&D